Actively Recruiting
Virtual Care to Improve Outcomes and Recovery From Heart Failure Hospitalization (VICTORY-HF) Randomized Trial
Led by Population Health Research Institute · Updated on 2024-12-31
891
Participants Needed
9
Research Sites
205 weeks
Total Duration
On this page
Sponsors
P
Population Health Research Institute
Lead Sponsor
H
Hamilton Health Sciences Corporation
Collaborating Sponsor
AI-Summary
What this Trial Is About
Heart failure is a major cause of death and hospital visits in Canada, and access to specialized care varies across regions. This research aims to create and test a virtual heart failure care program that allows patients to receive outpatient treatment and medication adjustments remotely. The study compares this virtual care to usual care to see if it improves health and treatment outcomes. A pilot phase was done to test the feasibility and acceptability of the virtual care approach and to finalize study procedures. Participants will receive virtual clinic visits for three months after a hospital or emergency visit for heart failure. During this time, their physiological data will be monitored remotely, and treatments will be adjusted as needed. The trial compares this virtual care to routine heart failure care provided by the treating physician. The virtual care period represents the main follow-up for medication and health status outcomes. Throughout the study, participants will be monitored for up to 180 days to assess clinical outcomes, with primary results collected at 30, 90, and 180 days. Researchers will evaluate a combination of health and treatment measures to understand how virtual care impacts recovery after heart failure hospitalization. The study includes assessments of patient health status and ongoing monitoring of their condition during the follow-up period.
CONDITIONS
Official Title
VIrtual Care To Improve Outcomes and RecoverY From Heart Failure Hospitalization
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients aged 18 years or older
- Being discharged after hospitalization or urgent visit for heart failure as primary diagnosis or significant complication
- Referred for initial cardiology consult within 1 week of hospitalization or urgent visit for heart failure
- Left ventricular ejection fraction less than 50% within the last 3 months
- NT-proBNP level greater than 900 pg/ml during hospital admission or within 7 days after discharge
- Have a mailing address for patient or caregiver
- Provide verbal consent
You will not qualify if you...
- Died or left hospital before medically advised discharge
- Unable to self-assess or communicate symptoms (e.g., dementia)
- Unable to engage with digital health technology or follow up
- Severe valve disease
- Recipient of or on waiting list for LVAD or cardiac transplant
- Complex congenital heart disease, hypertrophic obstructive cardiomyopathy, or amyloid cardiomyopathy
- Severe lung disease with symptoms on minimal exertion or on home oxygen
- Severe kidney disease with eGFR less than 30 mL/min/1.73m2
- Active malignancy
- Receiving palliative care or expected life expectancy less than 6 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 9 locations
1
St. Joseph's Healthcare Hamilton
Hamilton, Onatrio, Canada, L8N 4A6
Actively Recruiting
2
Hamilton General Hospital
Hamilton, Ontario, Canada, L8L 2X2
Actively Recruiting
3
Juravinski Hospital Cancer Centre
Hamilton, Ontario, Canada, L8V 5C2
Actively Recruiting
4
Thunder Bay Regional Health Sciences Centre
Thunder Bay, Ontario, Canada
Not Yet Recruiting
5
Unity Health Toronto
Toronto, Ontario, Canada
Not Yet Recruiting
6
Fattouma Bourguiba Hospital
Monastir, Tunisia
Actively Recruiting
7
Hedi Chaker Hospital
Sfax, Tunisia
Actively Recruiting
8
Sahloul Hospital
Sousse, Tunisia
Actively Recruiting
9
Military Hospital
Tunis, Tunisia
Actively Recruiting
Research Team
H
Harriette GC Van Spall, MD MPH
V
VICTORY-HF Project office
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here